Quest Diagnostics Inc
Change company Symbol lookup
Select an option...
DGX Quest Diagnostics Inc
AMTR ETRACS Alerian Midstream Energy Total Return Index ETN
INCAF Inca One Gold Corp
BCS Barclays PLC
MOR MorphoSys AG
GBNH Greenbrook TMS Inc
ASTL Algoma Steel Group Inc
REKR Rekor Systems Inc
PRDO Perdoceo Education Corp
SCCC Sachem Capital Corp
Go

Health Care : Health Care Providers & Services | Mid Cap Value
Company profile

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, accountable care organizations (ACOs) and direct contract entities (DCEs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provides insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company’s services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne and Quanum.

Closing Price
$136.68
Day's Change
3.70 (2.78%)
Bid
--
Ask
--
B/A Size
--
Day's High
136.95
Day's Low
132.52
Volume
(Below Average)
Volume:
798,159

10-day average volume:
921,318
798,159

Company Profile

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, accountable care organizations (ACOs) and direct contract entities (DCEs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provides insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company’s services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne and Quanum.

Valuation Ratios

Price/Earnings (TTM)
9.11x
Price/Sales (TTM)
1.50x
Price/Book (MRQ)
2.51x
Price/Cash Flow (TTM)
7.02x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

June 2022
Current Month
4.9M
Previous Month
4.9M
Percent of Float
4.19%
Days to Cover
6.4468 Days

Share Information

DGX is in a share class of common stock
Float
116.2M
Shares Outstanding
117.4M
Institutions Holding Shares
1,205
91.70%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Stephen H. RusckowskiChmn.
  • James E. DavisPres.
  • Mark J. GuinanCFO
  • Michael E. PrevoznikSr.VP
  • Mark DelaneySr.VP

Address

Insider Trading

During the most recent quarter, 60 shares were bought, and 454K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.